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Heteromorpha arborescens (syn. H. trifoliata) is used in traditional medicine for treatment of headache, pain and fevers. Aqueous and organic
extracts of roots, bark and leaves were assayed for inhibition of COX-1. The organic extracts of roots had good activity, the stems/bark some
activity and the leaves little activity. The water extracts were inactive. HPLC analysis revealed that falcarindiol, a known COX-1 inhibitor
previously isolated from leaves of H. arborescens, was not responsible for the activity.
© 2007 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Anti-inflammatory; COX-1; H. arborescens; Traditional medicine1. Introduction
Heteromorpha arborescens (Spreng.) Cham. & Schltdl. var.
abyssinica (A.Rich.) (syn. H. trifoliata) (Zulu: umbangandlala)
have many and varied uses in traditional medicine (Hutchings
et al., 1996; VanWyk andGericke, 2000). The plant has been used
bymany ethnic groups in central- and southernAfrica as a remedy
against headache, pain and fever (Watt and Breyer-Brandwijk,
1962; Arnold and Gulumian, 1984; Bearts and Lehmann, 1989;
Hutchings et al., 1996), indications that could be alleviated by
NSAID's via inhibition of the prostaglandin synthesis.
A 25% ethanolic stem bark and a methanolic leaf extract of
H. trifoliata were found to reduce tetradecanoylphorbol acetate
(TPA)-inducedmouse ear oedema, but showed onlyweak activity
in the carregeenan-induced mouse paw oedema assay (Recio
et al., 1995a). Two saponins, saikogenin B4 and saikogenin F, that
were active in the TPA-induced mouse ear oedema assay, were
isolated from the methanolic leaf extract (Recio et al., 1995b).
An ethanolic leaf extract of H. trifoliata has previously ex-
hibited good COX-1 inhibitory activity, whereas a water extract
was less active (McGaw et al., 1997). The polyacetylene⁎ Corresponding author. Fax: +45 35336041.
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doi:10.1016/j.sajb.2007.11.006falcarindiol, which is a known COX-1 inhibitor, has been
isolated from a petroleum ether extract of leaves of H. trifoliata
(Villegas et al., 1988). The hypothesis of the present study was
that COX-1 inhibitory activity of various extracts of different
plants parts of H. aborescens could be correlated with fal-
carindiol content.
2. Material and methods
2.1. Plant material
Roots, leaves and stems/bark of H. arborescens (Spreng.)
Cham. & Schltdl. var. abyssinica (A.Rich.) (Apiaceae) were
collected in March 2006 in the University of KwaZulu-Natal
Botanical Garden. Avoucher specimen is stored at the University
of KwaZulu-Natal Herbarium (No. Zschocke 2NU).
2.2. Extraction
Dried, powdered material (0.1 g) of roots, leaves or twigs
was extracted with 10 ml of water, methanol, acetone, dichlor-
omethane, ethyl acetate or hexane respectively for 15 min in an
ultrasound bath. The extraction procedure was repeated three
times. After filtration the extract was evaporated to dryness and
redissolved to a final concentration of 10 mg/ml.ts reserved.
Fig. 1. COX-1 inhibition of extracts of different plant parts of H. arborescens.
(W) water, (M) methanol, (A) acetone, (D) dichloromethane, (E) ethyl acetate,
(P) petroleum ether.
Fig. 2. HPLC chromatogrammes of petroleum ether and methanol extracts of
leaves, bark and roots of H. arborescens. The retention time of falcarindiol was
25.8 min.
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The COX-1 assay was performed according to Jäger et al.
(1996) with minor modifications. Fifty μl of COX-1 (Sigma)
(75 unit per sample) and 1250 μl co-factor solution (0.003 g
l-epinephrine, 0.003 g reduced gluthatione, 100 μl hematine in
10ml 0.1MTris-buffer, pH 8.2) and 200μl Tris-buffer per sample
were preincubated for 15 min on ice. Sixty μl of this solution was
added to the test solution consisting of 2.5 μl plant extract and
17.5 μl water and preincubated for 10 min at room temperature.
14C-arachidonic acid (20 μl) was added to this enzyme–extract
mixture and incubated for exactly 10min in a water bath at 37 °C.
The reaction was terminated with 10 μl 2 N HCl. A sample
redissolved to a final conc. of 10mg/mlwas tested in the assay at a
concentration of 250 μg/ml test solution. In each test, two types of
controls were run (2.5 μl ethanol and 17.5 μl water): backgrounds
inwhich the enzymewas inactivated withHCl before the addition
of 14C-arachidonic acid; and solvent blanks. The potent COX-1
inhibitor indomethacin was used as a positive control.
Unlabelled prostaglandin carrier solution (4 μl per sample)
was added to the reaction mixture. 14C-prostaglandins synthe-
sised in the assay were separated from unmetabolised arachi-
donic acid by column chromatography using silica columns. The
assay mixture was applied to the column with 1 ml eluent 1
(hexane:1,4-dioxane:acetic acid (350:150:1v/v/v)) followed by
an additional 4 ml eluent 1 to elute the unreacted arachidonic
acid. The prostaglandins were eluted into scintillation vials using
3 ml eluent 2 (ethyl acetate:methanol (85:15 v/v)). Four ml
scintillation fluid was added to the vials and the radioactivity
was counted after 1 h in the dark, using Beckmann LS 6000 LL
scintillation counter. The percentage inhibition of the extracts
was obtained by measuring the amount of radioactivity in the
solutions relative to the solvent blank.
2.4. HPLC-fingerprinting
0.1 g of roots, leaves, stems or flowers were extracted with
10 ml of methanol or petroleum ether for 60 min in an ultrasoundbath.. After filtration, the extracts were taken to dryness under
vacuum and redissolved to a final concentration of 10 mg/ml
before filtering through a 0.22μMfilter. 10μl extract was injected
into an HPLC (Waters 1525 Binary HPLC pump, 2996
Photodiode array detector) fitted with a Nucleosil 100-5 C-18
column (125×4.6 mm) from Macherey-Nagel, using water as
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1 ml/min. The following gradient systemwas used: 0 min 60%B,
15 min 60% B, 33 min 95% B (Zschocke et al., 1998). Authentic
falcarindiol was used for co-chromatography.
3. Results and discussion
The results from the COX-1 screening of extracts of different
plant parts are presented in Fig. 1. The organic extracts of the
roots generally exhibited the highest activity. The petroleum
ether extract of the twigs also had high inhibitory activity,
whereas the leaves in general did not show much activity. The
water extracts of all three plant parts were inactive.
As the known COX-1 inhibitor falcarindiol previously has
been isolated from a petroleum ether extract of leaves of
H. trifoliata, petroleum ether, as well as methanol, extracts
were subjected to HPLC-fingerprinting in order to detect fal-
carindiol content (Fig. 2). None of the extracts had a peak co-
chromatographing with falcarindiol, except the methanolic root
extract that had a small peak at the same retention time as
falcarindiol, but with a UV-spectrum different from the charac-
teristic polyacetylene UV-spectrum of falcarindiol, indicating
that falcarindiol was occurring in non-detectable levels, if at all
present in the plant material. Thus, falcarindiol cannot be
responsible for the observed COX-1 inhibition of the extracts.
It is possible that saikosaponins could be involved in the
inhibitory process. Previously, saikogenin B4 and saikogenin F
have been isolated from H. trifoliata (Recio et al., 1995b).
Saikogenin F has been shown to decrease prostaglandin E2
release from macrophages, though the mechanism of the
decrease was not established (Jung et al., 2005). However, it is
not known if these saikosaponins are present in root material,
which was the most active in the COX-1 assay. Further studies
are needed to isolate the compound(s) responsible for the anti-
inflammatory effect of H. arborescens.
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